These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29765443)

  • 1. Management of cardiac hemochromatosis.
    Aronow WS
    Arch Med Sci; 2018 Apr; 14(3):560-568. PubMed ID: 29765443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of hemochromatosis. Hemochromatosis Management Working Group.
    Barton JC; McDonnell SM; Adams PC; Brissot P; Powell LW; Edwards CQ; Cook JD; Kowdley KV
    Ann Intern Med; 1998 Dec; 129(11):932-9. PubMed ID: 9867745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
    Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac involvement in hemochromatosis.
    Gulati V; Harikrishnan P; Palaniswamy C; Aronow WS; Jain D; Frishman WH
    Cardiol Rev; 2014; 22(2):56-68. PubMed ID: 24503941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hereditary hemochromatosis].
    Dantas W
    Rev Gastroenterol Peru; 2001; 21(1):42-55. PubMed ID: 12170286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac iron overload following liver transplantation in patients without hereditary hemochromatosis or severe hepatic iron deposition.
    Papadodima S; Masia R; Stone JR
    Cardiovasc Pathol; 2019; 40():7-11. PubMed ID: 30763826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [28-year old patient with successfully treated dilatative cardiomyopathy].
    Burri E; Decker M; Eriksson U; Buser P; Hunziker L
    Internist (Berl); 2008 Mar; 49(3):349-52. PubMed ID: 18210019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
    Barton JC; Wiener HW; Acton RT; Go RC
    Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary hemochromatosis.
    Crownover BK; Covey CJ
    Am Fam Physician; 2013 Feb; 87(3):183-90. PubMed ID: 23418762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis.
    Hicken BL; Tucker DC; Barton JC
    Am J Gastroenterol; 2003 Sep; 98(9):2072-7. PubMed ID: 14499790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hereditary and acquired iron overload].
    de Korwin JD
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S304-12. PubMed ID: 17373275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the clinical use of hemochromatosis genetic testing.
    Lanktree MB; Lanktree BB; Paré G; Waye JS; Sadikovic B; Crowther MA
    Can J Gastroenterol Hepatol; 2015; 29(1):41-5. PubMed ID: 25706573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic hemochromatosis: serum ferritin concentrations during therapy by phlebotomy.
    Garry PJ; Saiki JH
    Clin Chem; 1982 Aug; 28(8):1806-8. PubMed ID: 7094303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis.
    Casanova-Esteban P; Guiral N; Andrés E; Gonzalvo C; Mateo-Gallego R; Giraldo P; Paramo JA; Civeira F
    Metabolism; 2011 Jun; 60(6):830-4. PubMed ID: 20846699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous excretion of iron and ferritin (through Al-hijamah) as a novel treatment for iron overload in beta-thalassemia major, hemochromatosis and sideroblastic anemia.
    El Sayed SM; Abou-Taleb A; Mahmoud HS; Baghdadi H; Maria RA; Ahmed NS; Nabo MM
    Med Hypotheses; 2014 Aug; 83(2):238-46. PubMed ID: 24857772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron deficiency and overload.
    Beutler E; Hoffbrand AV; Cook JD
    Hematology Am Soc Hematol Educ Program; 2003; ():40-61. PubMed ID: 14633776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary hemochromatosis.
    Walker EM; Wolfe MD; Norton ML; Walker SM; Jones MM
    Ann Clin Lab Sci; 1998; 28(5):300-12. PubMed ID: 9784832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary hemochromatosis.
    Franchini M; Veneri D
    Hematology; 2005 Apr; 10(2):145-9. PubMed ID: 16019461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.